Barry D. Quart, Director at Kiniksa Pharmaceuticals International, plc (KNSA), sold 47,996 shares at $30.26 ($1.5M) on 2025-06-09, disclosed to the SEC on 2025-06-11.
Open-market sale of $1.5M KNSA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.26 | 6,900 | $209K | 14.3% |
| 2 | $30.36 | 8,212 | $249K | 17.1% |
| 3 | $30.36 | 8,212 | $249K | 17.1% |
| 4 | $30.39 | 12,336 | $375K | 25.7% |
| 5 | $30.39 | 12,336 | $375K | 25.7% |
| Total | $30.36 avg | 47,996 |
| $1.5M |
| 100% |
| Filing → |
| KNSA | SELL | 2026-02-12 | $126K | — | Filing → |
| KNSA | SELL | 2026-02-04 | $722K | — | Filing → |
| KNSA | SELL | 2025-12-17 | $1.7M | — | Filing → |